Loading stock data…
Loading stock data…
US$0.67
Get one email when TRAW crosses your level. Checked every 15 minutes during market hours.
▲ +0.01 (1.05%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
34.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.14
Bullish momentumMACD above its signal line (-0.15).
50-day average
1.20
Price belowShort-term trend reference.
200-day average
1.76
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Traws Pharma Inc. is a distinguished name in the pharmaceutical industry, primarily focused on the research, development, and commercialization of innovative treatments for a diverse range of medical conditions. With a strong commitment to advancing medical science, Traws Pharma operates at the intersection of cutting-edge biotechnology and classic pharmaceutical expertise. Its product pipeline includes groundbreaking therapies targeting oncology, rare genetic disorders, and metabolic diseases, …
www.trawspharma.com0 strong buy · 0 buy · 4 hold · 1 sell · 2 strong sell (7 analysts, 2026-07-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-17 | 3.12 | 3.16 | ✓ Beat |
| 2026-05-26 | 2.34 | 3.14 | ✓ Beat |
| 2026-05-15 | -0.56 | -0.52 | ✓ Beat |
| 2026-04-15 | -1.91 | -0.71 | ✓ Beat |
| 2025-11-13 | -9.16 | -0.34 | ✓ Beat |
| 2025-03-30 | — | 26.61 | — |
| 2024-11-14 | -6.25 | -8.81 | ✗ Miss |
| 2024-08-15 | -6.25 | -121.75 | ✗ Miss |
Companies in the same industry, via Finnhub